Top compounds associated with response to EBF4


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib CTRPv2 pan-cancer AAC 0.014 0.7
mRNA CCT007093 GDSC1000 pan-cancer AAC 0.014 0.7
mRNA rTRAIL GDSC1000 pan-cancer AAC 0.014 0.7
mRNA MG-132 CTRPv2 pan-cancer AAC -0.028 0.7
mRNA linifanib GDSC1000 pan-cancer AAC 0.014 0.7
mRNA Axitinib GDSC1000 pan-cancer AAC 0.014 0.7
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.011 0.7
mRNA Bosutinib GDSC1000 pan-cancer AAC 0.013 0.7
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA CP724714 GDSC1000 pan-cancer AAC 0.013 0.7
Download CSV